XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 457 $ 1,477
Prepaid expenses 3,303 2,065
Total Current Assets 3,760 3,542
Intellectual property, net 217,700 222,071
TOTAL ASSETS 221,460 225,613
Current Liabilities    
Accounts payable 8,775 6,304
Accrued expenses 6,410 350
Interest payable 42,205 40,232
Note payable 50,000 50,000
Convertible note 40,000 40,000
Loan from related party 641,544 627,044
Total Current Liabilities 788,934 763,930
TOTAL LIABILITIES 788,934 763,930
STOCKHOLDERS' DEFICIT    
Preferred Stock: $0.0001 par value; 10,000,000 shares authorized; 500,000 shares issued and outstanding at March 31, 2019 and December 31, 2018 50 50
Common Stock: $0.0001 par value; 200,000,000 shares authorized; 75,310,000 shares issued and outstanding at March 31, 2019 and December 31, 2018 7,531 7,531
Additional paid-in capital 1,616,273 1,616,273
Accumulated deficit (2,191,328) (2,162,171)
TOTAL STOCKHOLDERS' DEFICIT (567,474) (538,317)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT $ 221,460 $ 225,613